Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction

Por Emanuele Bruni, Albrecht Reichle, Manuel Scimeca, Elena Bonanno, Elena Bonanno, Lina Ghibelli
Publicado em 2018-11-01

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Por Dennis Christoph Harrer, Karin Menhart, Stephanie Mayer, Wolfgang Herr, Albrecht Reichle, Martin Vogelhuber
Publicado em 2020-10-01

C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation

Por Albrecht Reichle, Jochen Grassinger, Klaus Bross, Jochen Wilke, Thomas Suedhoff, Bernhard Walter, Wolf-Ferdinand Wieland, Anna Berand, Reinhard Andreesen
Publicado em 2006-01-01

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis

Por Daniel Heudobler, Michael Rechenmacher, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Simone Thomas, Tobias Pukrop, Christina Hackl, Wolfgang Herr, Lina Ghibelli, Christopher Gerner, Albrecht Reichle
Publicado em 2018-11-01

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

Por Matthias A. Fante, Mona Felsenstein, Stephanie Mayer, Michael Gerken, Michael Gerken, Monika Klinkhammer-Schalke, Monika Klinkhammer-Schalke, Wolfgang Herr, Martin Vogelhuber, Albrecht Reichle, Daniel Heudobler, Daniel Heudobler
Publicado em 2022-05-01